热门资讯> 正文
Purple Biotech announces receipt of Nasdaq minimum bid price notification
2025-10-21 04:08
- Purple Biotech Ltd (NASDAQ:PPBT) said on Monday it received a notice from Nasdaq that its American Depositary Shares (ADSs) have been below the $1 minimum bid price required for continued listing for 30 consecutive trading days.
- The company has 180 days, until April 14, 2026, to regain compliance by maintaining a closing price of $1 or more for ten consecutive business days.
- If unsuccessful, Nasdaq may grant an additional 180-day cure period, subject to other listing requirements.
- Trading of PPBT ADSs will continue during the compliance period.
- PPBT closed -5.24% at $0.576.
- Source: Press Release
More on Purple Biotech
- Purple Biotech prices $6M public offering, $12M potential via warrants; shares down
- Seeking Alpha’s Quant Rating on Purple Biotech
- Historical earnings data for Purple Biotech
- Financial information for Purple Biotech
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
